BPA
Beacon Pointe Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,917
| Closed | -$211K | – | 1239 |
|
|
2024
Q4 | $211K | Buy |
+4,917
| New | +$211K | ﹤0.01% | 1120 |
|
|
2022
Q3 | – | Sell |
-4,817
| Closed | -$202K | – | 1070 |
|
|
2022
Q2 | $202K | Buy |
4,817
+173
| +4% | +$7.26K | ﹤0.01% | 967 |
|
|
2022
Q1 | $210K | Buy |
+4,644
| New | +$210K | ﹤0.01% | 1105 |
|
|
2021
Q2 | – | Sell |
-4,230
| Closed | -$213K | – | 836 |
|
|
2021
Q1 | $213K | Buy |
+4,230
| New | +$213K | 0.01% | 488 |
|